Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing elderly population globally coupled with rising chronic diseases
3.2.1.2 Technological advancements in biomaterials, implant design, and manufacturing processes
3.2.1.3 Growing demand for cosmetic surgery
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of impants
3.2.2.2 Strict regulatory requirements for approval of bioimplants
3.3 Growth potential analysis
3.4 Technology landscape
3.5 Regulatory landscape
3.6 Pricing analysis
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Cardiovascular implants
5.3 Orthopedic implants
5.3.1 Joint implants
5.3.2 Bone implants
5.3.3 Soft tissue implants
5.4 Ophthalmic implants
5.5 Spinal implants
5.6 Dental implants
5.7 Breast implants
Chapter 6 Market Estimates and Forecast, By Material Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Biomaterial metal
6.2.1 Titanium
6.2.2 Gold
6.2.3 Silver
6.2.4 Platinum
6.3 Alloys
6.4 Ceramic
6.5 Polymers
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Cardiac surgery
7.3 Trauma and orthopedic surgery
7.4 Ophthalmic surgery
7.5 Neurological surgery
7.6 Dental surgery
7.7 Cosmetic and reconstructive surgery
Chapter 8 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Specilaty clinics
8.4 ASCs
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 Arthrex inc.
10.3 aap Implantate AG
10.4 Biotronik SE & Co. KG
10.5 Cochlear Ltd.
10.6 DePuy Synthes (Johnson & Johnson)
10.7 Edwards Lifesciences Corporation
10.8 LifeNet Health
10.9 Medtronic plc
10.10 Organogenesis Inc.
10.11 Smith & Nephew plc
10.12 Stryker Corporation
10.13 Zimmer Biomet Holdings Inc.